A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.
AMA J Ethics. 2021;23(9):E712-720. doi:
10.1001/amajethics.2021.712.
An examination of some of the factors that can weaken the therapeutic nature of the patient-physician relationship and how a physician can resolve them in the patient's best interest.
When patients request drugs for nonmedical reasons, the most effective intervention may be to explore with the patient his or her reasons for using drugs to make lifestyle changes.